EAPIF
Price
$3.20
Change
+$0.11 (+3.56%)
Updated
Sep 30 closing price
Capitalization
361.01M
HLN
Price
$9.04
Change
+$0.22 (+2.49%)
Updated
Oct 8 closing price
Capitalization
39.66B
21 days until earnings call
Interact to see
Advertisement

EAPIF vs HLN

Header iconEAPIF vs HLN Comparison
Open Charts EAPIF vs HLNBanner chart's image
EUROAPI SA
Price$3.20
Change+$0.11 (+3.56%)
Volume$101
Capitalization361.01M
Haleon
Price$9.04
Change+$0.22 (+2.49%)
Volume$16.01M
Capitalization39.66B
EAPIF vs HLN Comparison Chart in %
EAPIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EAPIF vs. HLN commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EAPIF is a Hold and HLN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (EAPIF: $3.20 vs. HLN: $9.04)
Brand notoriety: EAPIF and HLN are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: EAPIF: 27% vs. HLN: 183%
Market capitalization -- EAPIF: $361.01M vs. HLN: $39.66B
EAPIF [@Pharmaceuticals: Generic] is valued at $361.01M. HLN’s [@Pharmaceuticals: Generic] market capitalization is $39.66B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EAPIF’s FA Score shows that 0 FA rating(s) are green whileHLN’s FA Score has 1 green FA rating(s).

  • EAPIF’s FA Score: 0 green, 5 red.
  • HLN’s FA Score: 1 green, 4 red.
According to our system of comparison, EAPIF is a better buy in the long-term than HLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EAPIF’s TA Score shows that 2 TA indicator(s) are bullish while HLN’s TA Score has 6 bullish TA indicator(s).

  • EAPIF’s TA Score: 2 bullish, 3 bearish.
  • HLN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, HLN is a better buy in the short-term than EAPIF.

Price Growth

EAPIF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while HLN (@Pharmaceuticals: Generic) price change was +0.33% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.66%. For the same industry, the average monthly price growth was +4.90%, and the average quarterly price growth was +63.90%.

Reported Earning Dates

HLN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.66% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HLN($39.7B) has a higher market cap than EAPIF($361M). HLN has higher P/E ratio than EAPIF: HLN (20.07) vs EAPIF (7.92). EAPIF YTD gains are higher at: 6.667 vs. HLN (-3.575). HLN has higher annual earnings (EBITDA): 2.71B vs. EAPIF (-37.9M). HLN has more cash in the bank: 676M vs. EAPIF (57.8M). EAPIF has less debt than HLN: EAPIF (68.4M) vs HLN (8.45B). HLN has higher revenues than EAPIF: HLN (11B) vs EAPIF (883M).
EAPIFHLNEAPIF / HLN
Capitalization361M39.7B1%
EBITDA-37.9M2.71B-1%
Gain YTD6.667-3.575-186%
P/E Ratio7.9220.0739%
Revenue883M11B8%
Total Cash57.8M676M9%
Total Debt68.4M8.45B1%
TECHNICAL ANALYSIS
Technical Analysis
EAPIFHLN
RSI
ODDS (%)
Bearish Trend 1 day ago
33%
Bullish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
29%
Bullish Trend 1 day ago
61%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
44%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
62%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
34%
Bullish Trend 1 day ago
51%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
31%
Bearish Trend 1 day ago
41%
Advances
ODDS (%)
N/A
Bullish Trend 1 day ago
55%
Declines
ODDS (%)
N/A
Bearish Trend 15 days ago
52%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
48%
Aroon
ODDS (%)
Bearish Trend 1 day ago
40%
Bearish Trend 1 day ago
43%
View a ticker or compare two or three
Interact to see
Advertisement
EAPIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GGUS64.130.60
+0.95%
Goldman Sachs MktBt Russell LgCpGrEqETF
ESG155.340.76
+0.49%
FlexShares STOXX US ESG Select ETF
CAFG25.780.11
+0.43%
Pacer US Small Cap Cash Cows Gr Ldrs ETF
DXJ133.320.52
+0.39%
WisdomTree Japan Hedged Equity ETF
BIDD28.540.09
+0.32%
iShares International Dividend ActiveETF

EAPIF and

Correlation & Price change

A.I.dvisor tells us that EAPIF and HLN have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EAPIF and HLN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EAPIF
1D Price
Change %
EAPIF100%
N/A
HLN - EAPIF
14%
Poorly correlated
+2.49%
HLNCF - EAPIF
11%
Poorly correlated
+2.71%
IXHL - EAPIF
7%
Poorly correlated
-1.19%
AKAN - EAPIF
2%
Poorly correlated
+4.26%
ALVO - EAPIF
2%
Poorly correlated
+0.46%
More

HLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLN has been loosely correlated with HLNCF. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HLN jumps, then HLNCF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLN
1D Price
Change %
HLN100%
+2.49%
HLNCF - HLN
49%
Loosely correlated
+2.71%
TAK - HLN
42%
Loosely correlated
-1.04%
ZTS - HLN
39%
Loosely correlated
+0.50%
PRGO - HLN
32%
Poorly correlated
-0.14%
VTRS - HLN
29%
Poorly correlated
-1.68%
More